Search
for

    Sort by

    Research 301–330 of 1000+

    1. Long-term dutasteride therapy in men with benign prostatic hyperplasia alters glucose and lipid profiles and increases severity of erectile dysfunction Hormone Molecular Biology and Clinical Investigation · 2017 · 20 citations
    2. Finasteride, not tamsulosin, increases severity of erectile dysfunction and decreases testosterone levels in men with benign prostatic hyperplasia Hormone Molecular Biology and Clinical Investigation · 2015 · 20 citations
    3. Ezetimibe Reduces Enlarged Prostate in an Animal Model of Benign Prostatic Hyperplasia The Journal of Urology · 2010 · 20 citations
    4. Efficacy and safety of 5 alpha-reductase inhibitor monotherapy in patients with benign prostatic hyperplasia: A meta-analysis PLOS ONE · 2018 · 19 citations
    5. A Review on Steroidal 5α-Reductase Inhibitors for Treatment of Benign Prostatic Hyperplasia Current Medicinal Chemistry · 2011 · 17 citations
    6. α-spinasterol from Melandrium firmum attenuates benign prostatic hyperplasia in a rat model Molecular Medicine Reports · 2014 · 15 citations
    7. The prevention of benign prostatic hyperplasia (bph) Medical Hypotheses · 2016 · 12 citations
    8. The corpus cavernosum after treatment with dutasteride or finasteride: A histomorphometric study in a benign prostatic hyperplasia rodent model Asian Journal of Andrology · 2018 · 11 citations
    9. Androgenetic alopecia and polymorphism of the androgen receptor gene (SNP rs6152) in patients with benign prostate hyperplasia or prostate cancer Journal of The European Academy of Dermatology and Venereology · 2014 · 11 citations
    10. Preventive Effects of Monascus on Androgen-Related Diseases: Androgenetic Alopecia, Benign Prostatic Hyperplasia, and Prostate Cancer Journal of Agricultural and Food Chemistry · 2013 · 11 citations
    11. Therapeutic Considerations Related to Finasteride Administration in Male Androgenic Alopecia and Benign Prostatic Hyperplasia Farmacia · 2017 · 9 citations
    12. A herbal formula, comprising Panax ginseng and bee-pollen, inhibits development of testosterone-induced benign prostatic hyperplasia in male Wistar rats Saudi Journal of Biological Sciences · 2015 · 8 citations
    13. Upregulation of mir-1199-5p is associated with reduced type 2 5-α reductase expression in benign prostatic hyperplasia BMC Urology · 2022 · 6 citations
    14. Inhibitory effects of TripTripterygium wilfordii multiglycoside on benign prostatic hyperplasia in rats 2015 · 5 citations
    15. Re: Androgenetic Alopecia as an Early Marker of Benign Prostatic Hyperplasia The Journal of Urology · 2012 · 5 citations
    16. Effect of Citrullus colocynthis Schard on Testosterone-Induced Benign Prostatic Hyperplasia Journal of Complementary and Integrative Medicine · 2009 · 5 citations
    17. Presence of Codes for Indication for Use in Clinical Practice Research Datalink Aurum: An Assessment of Benign Prostatic Hyperplasia Treatments Clinical Epidemiology · 2022 · 4 citations
    18. Dihydroartemisinin attenuates benign prostatic hyperplasia in rats by inhibiting prostatic epithelial cell proliferation Annals of Translational Medicine · 2021 · 4 citations
    19. Pharmacological Effects of the Lipidosterolic Extract from Kigelia africana Fruits in Experimental Benign Prostatic Hyperplasia Induced by Testosterone in Sprague Dawley Rats Journal of Experimental Pharmacology · 2023 · 3 citations
    20. Phytotherapy in Benign Prostatic Hyperplasia Elsevier eBooks · 2018 · 3 citations
    21. Is there a relationship between androgenic alopecia and benign prostatic hyperplasia? DOAJ (DOAJ: Directory of Open Access Journals) · 2015 · 3 citations
    22. Biochemical and Histopathological evaluation of prostatic tissue under effect of Pterostilbene in benign prostatic hyperplasia rat model Al Mustansiriyah Journal of Pharmaceutical Sciences · 2023 · 2 citations
    23. Re: Risk of Erectile Dysfunction Associated with Use of 5α-Reductase Inhibitors for Benign Prostatic Hyperplasia or Alopecia: Population Based Studies Using the Clinical Practice Research Datalink European Urology · 2017 · 2 citations
    24. Finasteride: Middle-Age Cure-All for Alopecia and Benign Prostatic Hyperplasia?–Reply–II Mayo Clinic Proceedings · 2006 · 2 citations
    25. Hydroxychloroquine modulates the progression of experimentally induced benign prostatic hyperplasia in rats via targeting EGFR/ERK/STAT3 and AR/FOXO1/TRAIL pathways: computational and in vivo studies Scientific Reports · 2025 · 1 citations
    26. Comparison of combination therapy with tamsulosin and dutasteride or finasteride in patients with benign prostatic hyperplasia: a randomized clinical trial African Journal of Urology · 2024 · 1 citations
    27. Zhuangyao Jianshen pill ameliorates testosterone-induced benign postatic hyperplasia in rats. PubMed · 2024 · 1 citations
    28. Pharmacological Approaches in Managing Symptomatic Relief of Benign Prostatic Hyperplasia: A Comprehensive Review Curēus · 2023 · 1 citations
    29. Suicidal risk associated with finasteride versus dutasteride among men treated for benign prostatic hyperplasia: nationwide cohort study Scientific Reports · 2023 · 1 citations
    30. Inhibition of Proliferation of LNCaP Prostate Cells by Corni Fructus Extract Is Associated with a Decrease in the Expression of Benign Prostatic Hyperplasia-Causing Factors Journal of Korean Medicine for Obesity Research · 2021 · 1 citations